Home › Funds › Vanguard › Vanguard U.S. Value Factor ETF
Fund family: Vanguard · Filed by VANGUARD WELLINGTON FUND (CIK 105563) · SEC series S000061305
Ticker: VFVA (C000198470)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 6,878 with, 185 against, 0 abstentions (not counted as with management); 1 items carried no recommendation. Shareholder proposals: 12 FOR, 170 AGAINST, 0 abstained, by the filing’s own vote-source field.
The same two figures as Vanguard’s manager page (1,379,791 ballot items across 136 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | Vanguard | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 99.3% | 6,723 | 94.5% | 1,082,514 |
| Backed environmental and social shareholder proposals at US companies | 0.0% | 79 | 0.9% | 6,718 |
Each ballot item this fund voted is set against the votes of the other Vanguard funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted differently from most Vanguard funds on 1 item (0.1% of the 6,967 items where a comparison was possible).
| Company | Meeting | Item | This fund | Most Vanguard funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| JAKKS Pacific, Inc. | 2026-06-05 | To conduct an advisory vote on executive compensation. | For | AGAINST — 4 of 7 Vanguard funds | For | Not approved, 47.6% support |
Download all 1 differences (CSV)
The same votes as “with management” above, by the sector of the company voted on. 96.3% of this fund’s 7,063 such votes could be given a sector; the other 260 (3.7%) are at companies without one and are not in the table.
| Sector | Votes | Against management | Share |
|---|---|---|---|
| Finance | 2,175 | 29 | 1.3% |
| Consumer Discretionary | 1,623 | 50 | 3.1% |
| Health Care | 777 | 26 | 3.3% |
| Technology | 745 | 33 | 4.4% |
| Industrials | 662 | 19 | 2.9% |
| Energy | 294 | 6 | 2.0% |
| Consumer Staples | 290 | 15 | 5.2% |
| Telecommunications | 89 | 7 | 7.9% |
| Basic Materials | 83 | 0 | 0.0% |
| Utilities | 34 | 0 | 0.0% |
| Miscellaneous | 31 | 0 | 0.0% |
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 5,112 | 4 |
| Say-on-Pay | 653 | 0 |
| Audit-related | 637 | 0 |
| Compensation | 269 | 6 |
| Corporate Governance | 219 | 85 |
| Capital Structure | 85 | 1 |
| Environment or Climate | 35 | 35 |
| Extraordinary Transactions | 29 | 1 |
| Shareholder Rights and Defenses | 27 | 9 |
| Other Social Issues | 26 | 25 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| Alight, Inc. | June 10, 2026 | $83M | 8 | 0 |
| Marathon Petroleum Corporation | April 29, 2026 | $21M | 8 | 0 |
| Micron Technology, Inc. | January 15, 2026 | $19M | 12 | 1 |
| EOG Resources, Inc. | May 20, 2026 | $17M | 11 | 0 |
| FedEx Corporation | September 29, 2025 | $16M | 17 | 1 |
| Bristol-Myers Squibb Company | May 5, 2026 | $15M | 15 | 1 |
| CVS Health Corporation | May 14, 2026 | $15M | 17 | 1 |
| The Cigna Group | April 22, 2026 | $15M | 15 | 1 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| January 15, 2026 | Micron Technology, Inc. | SHAREHOLDER PROPOSAL REQUESTING AMENDMENT TO SHAREHOLDER SPECIAL MEETING RIGHT. Shareholder proposal | Against | For |
| September 29, 2025 | FedEx Corporation | Stockholder proposal regarding independent board chairman. Shareholder proposal | Against | For |
| May 5, 2026 | Bristol-Myers Squibb Company | Shareholder Proposal on the Adoption of a Board Policy that the Chairperson of the Board be an Independent Director Shareholder proposal | Against | For |
| May 14, 2026 | CVS Health Corporation | Stockholder Proposal for Reducing the Threshold for Our Stockholder Right to Act By Written Consent. Shareholder proposal | Against | For |
| April 22, 2026 | The Cigna Group | Shareholder Proposal - Shareholder Right to Act by Written Consent Shareholder proposal | Against | For |
| May 28, 2026 | Salesforce, Inc. | A stockholder proposal requesting the adoption of cumulative voting for director elections, if properly presented at the meeting. Shareholder proposal | Against | For |
| June 1, 2026 | UnitedHealth Group Incorporated | If properly presented at the 2026 Annual Meeting of Shareholders, the shareholder proposal requesting the adoption of a policy to require any Board Chair to be independent. Shareholder proposal | Against | For |
| June 2, 2026 | General Motors Company | Shareholder Proposal Regarding Separation of Chair and CEO Roles Shareholder proposal | Against | For |
| June 2, 2026 | General Motors Company | Shareholder Proposal Requesting a Report on Human Rights Standards for Indigenous Peoples Shareholder proposal | Against | For |
| May 21, 2026 | Verizon Communications Inc. | Board oversight of material issues related to climate change Shareholder proposal | Against | For |
| May 21, 2026 | Verizon Communications Inc. | Independent board chair Shareholder proposal | Against | For |
| May 26, 2026 | Merck & Co., Inc. | Shareholder proposal regarding a report on DEI risks in federal contracting. Shareholder proposal | Against | For |
Meetings with a proxy contest or competing nominees (4 in 2025-2026), and how the fund voted the items on its ballot.
7,112 ballot items at 651 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, Vanguard U.S. Value Factor ETF (VFVA) voted at 651 shareholder meetings of 637 companies, on 7,112 ballot items in all. Where management made a recommendation, the fund followed it on 97.4% of the items and voted against it 185 times. Its most frequent area of disagreement was corporate governance (85 of its votes against management). It voted FOR 6.6% of the 182 shareholder proposals on which it cast a FOR or AGAINST vote. It voted FOR the board's own proposals more often than Vanguard's funds as a whole (99.3% against 94.5%). It voted differently from most Vanguard funds on 1 item. 4 of its meetings were contested.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Vanguard’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.